In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas

被引：3
|
作者：
Tarantelli, Chiara [1 ]
Gaudio, Eugenio [1 ]
Cascione, Luciano [1 ,2 ]
Stathis, Anastasios [3 ]
Zucca, Emanuele [3 ]
Bertoni, Francesco [1 ]
机构：
[1] USI, IOR, Bellinzona, Switzerland
[2] SIB, Lausanne, Switzerland
[3] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 186卷 / 01期
关键词：
chemotherapy; lymphomas; ibrutinib; idelalisib; T-cell lymphoma; AZA-ANTHRACENEDIONE; SINGLE-AGENT; PHASE-I/II; COMBINATION; BBR-2778;
D O I：
10.1111/bjh.15727
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 152
页数：4
相关论文
共 50 条
  • [41] Development and characterization of a human in vitro resorption assay: Demonstration of utility using novel antiresorptive agents
    James, IE
    Lark, MW
    Zembryki, D
    Lee-Rykaczewski, EV
    Hwang, SM
    Tomaszek, TA
    Belfiore, P
    Gowen, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) : 1562 - 1569
  • [42] Subcutaneous phaeohyphomycosis in transplant recipients:: review of the literature and demonstration of in vitro synergy between antifungal agents
    Clancy, CJ
    Wingard, JR
    Nguyen, MH
    MEDICAL MYCOLOGY, 2000, 38 (02) : 169 - 175
  • [43] In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy
    Xiao, Qicai
    Mai, Bingjie
    Nie, Yichu
    Yuan, Chuang
    Xiang, Menghua
    Shi, Zihan
    Wu, Juan
    Leung, Wingnang
    Xu, Chuanshan
    Yao, Shao Q.
    Wang, Pan
    Gao, Liqian
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (10) : 11588 - 11596
  • [44] In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans
    Iida, Y
    Oh, KB
    Saito, M
    Matsuoka, H
    Kurata, H
    PLANTA MEDICA, 2000, 66 (05) : 435 - 438
  • [45] Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
    Herrera, F. G.
    Vidal, L.
    Oza, A.
    Milosevic, M.
    Fyles, A.
    REVIEWS ON RECENT CLINICAL TRIALS, 2008, 3 (02) : 111 - 120
  • [46] Synergism of lurbinectedin (PM01183) combined with 5-fluorouracil (5-FU): in vitro and in vivo studies
    Aviles, Pablo
    Jose Guillen, Maria
    Galmarini, Carlos
    Francisco Garcia, Luis
    Lopez, Raquel
    Nunez, Praxedes
    Moneo, Victoria
    Cuevas, Carmen
    CANCER RESEARCH, 2013, 73 (08)
  • [47] Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents
    Tietz, Ole
    Kamaly, Nazila
    Smith, Graham
    Shamsaei, Elham
    Bhakoo, Kishore K.
    Long, Nicholas J.
    Aboagye, Eric O.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 3 (04): : 372 - 383
  • [48] In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
    Zuo, Guo-Ying
    Zhang, Xin-Juan
    Han, Jun
    Li, Yu-Qing
    Wang, Gen-Chun
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [49] In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients
    Ying, Ruoyan
    Huang, Xiaochen
    Gao, Yaxian
    Wang, Jie
    Liu, Yidian
    Sha, Wei
    Yang, Hua
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 3729 - 3736
  • [50] Marked Synergism In Vitro with the Histone Deacetylase Inhibitor LBH-589 and Classical Agents: Potential New Leads for Combination Therapy
    Budman, D. R.
    Calabro, A.
    Tai, J.
    CANCER RESEARCH, 2009, 69 (24) : 785S - 785S
12345